I am a translational research scientist specialised in microbiology and immuno-oncology, currently working at the University of Sydney’s Li Ka Shing Cell & Gene Therapy Program, affiliated with Royal Prince Alfred Hospital. My current projects focus on the research parallel to a clinical trial using mesothelin-targeted CAR T cell therapy against pancreatic cancer delivered intra-tumourally. Previously I worked at GSK in oncology cell therapy, where I progressed many CAR and TCR T cell therapy projects from early development to clinical trials.
I am a translational research scientist specialised in microbiology and immuno-oncology, currently working at the University of Sydney’s Li Ka Shing Cell & Gene Therapy Program, affiliated with Royal Prince Alfred Hospital. My current projects focus on the research parallel to a clinical trial using mesothelin-targeted CAR T cell therapy against pancreatic cancer delivered intra-tumourally. Previously I worked at GSK in oncology cell therapy, where I progressed many CAR and TCR T cell therapy projects from early development to clinical trials.